mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.2 |
mRNA |
erismodegib |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.3 |
mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.3 |
mRNA |
GSK-650394 |
GDSC1000 |
pan-cancer |
AAC |
0.042 |
0.3 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.3 |
mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
0.038 |
0.3 |
mRNA |
SB52334 |
GDSC1000 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.3 |
mRNA |
KU-55933 |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.3 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.3 |